Back

Persistent pulmonary hypertension after mitral valve surgery is related to post-operative adverse in-hospital events and mortality.

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Hemodynamics, prognostic markers, and precision monitoring in structural heart disease and heart transplantation Intervention Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Miss Romee Esther Heijting

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Survival trajectories in post-transplant patients receiving "acceptably" undersized donor hearts: a long-term analysis
Doctor S. Kumar (Cambridge, GB)
Abstract
Presentation thumbnail
Predictors of heart failure rehospitalization in mitral transcatheter edge-to-edge repair (M-TEER) based on residual mitral regurgitation: a single center study
Doctor M. Biswas (Pittsburgh, US)
Abstract
Presentation thumbnail
Endocarditis by candida spp and association with heart failure: a systematic review of case reports
Doctor C. Vigil Lopez (Ensenada, MX)
Abstract
Presentation thumbnail
Predictors of lv function recovery one year after TAVR
Doctor F. Nascimento Ferreira (Lisbon, PT)
Abstract
Presentation thumbnail
Design of a national Swedish study evaluating donor-derived cell-free DNA as a diagnostic biomarker in heart transplantation using next-generation sequencing
Doctor I. Haugen Loefman (Stockholm, SE)
Abstract

Access the full session

Session thumbnail
Hemodynamics, prognostic markers, and precision monitoring in structural heart disease and heart transplantation

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources